These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8068577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X, Li G, Abdel-Rahman AA.
    Eur J Pharmacol; 2005 May 09; 514(2-3):191-9. PubMed ID: 15910806
    [Abstract] [Full Text] [Related]

  • 5. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
    Haxhiu MA, Dreshaj I, Schäfer SG, Ernsberger P.
    J Cardiovasc Pharmacol; 1994 May 09; 24 Suppl 1():S1-8. PubMed ID: 7533221
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C, Niederhoffer N, Szabo B.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr 09; 359(4):262-71. PubMed ID: 10344524
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. From alpha and beta to I1: an overview of sympathetic receptors involved in blood pressure control targets for drug treatment.
    van Zwieten PA.
    J Cardiovasc Pharmacol; 1996 Apr 09; 27 Suppl 3():S5-10. PubMed ID: 8872294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN, Owens CW, Graham BR.
    J Hum Hypertens; 1997 Aug 09; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [Abstract] [Full Text] [Related]

  • 15. Central imidazoline receptors and centrally acting anti-hypertensive agents.
    Head GA, Burke SL, Chan CK.
    Clin Exp Hypertens; 1997 Aug 09; 19(5-6):591-605. PubMed ID: 9247741
    [Abstract] [Full Text] [Related]

  • 16. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK, Burke SL, Zhu H, Piletz JE, Head GA.
    Neuroscience; 2005 Aug 09; 132(4):991-1007. PubMed ID: 15857704
    [Abstract] [Full Text] [Related]

  • 17. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA.
    J Hypertens; 1997 Feb 09; 15(2):117-25. PubMed ID: 9469786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation.
    Bousquet P.
    Am J Hypertens; 2000 Jun 09; 13(6 Pt 2):84S-88S. PubMed ID: 10921526
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.